Frequency Therapeutics Profit Margin 2018-2021 | FREQ
Current and historical gross margin, operating margin and net profit margin for Frequency Therapeutics (FREQ) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Frequency Therapeutics net profit margin as of June 30, 2021 is -152%.
|Frequency Therapeutics Annual Profit Margins
|Frequency Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Frequency Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company's lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss. Frequency Therapeutics Inc. is headquartered in Woburn, Mass.